AzTrials
AzTrials

Cesarean Wound Disruption With Postnatal ComplicationNCT06543329

Comparative Analysis of Subcuticular Suture Materials in Cesarean Section

A study testing polyglactin 910, poliglecaprone 25 and polypropylene in people with Cesarean Wound Disruption With Postnatal Complication, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

1.1. Background and Rationale Cesarean section is one of the most common surgical procedures performed worldwide. The choice of suture material for closing the skin incision is crucial, as it can influence wound healing, the risk of wound complications, and the cosmetic outcome. Read more about this study

Who is it for?
Ages 20 to 45 years, women onlyHealthy volunteers can take part
What is being tested?
polyglactin 910, poliglecaprone 25 and polypropylene
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteEgypt
Study dates
1 Aug 2024to 30 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Women aged 20-45 years old.
  • BMI = or more than 40 kg/m2
  • Primigravida or not more than the previous 1 cesarean section.
  • Will undergo a lower-segment cesarean section.
  • Hb: ≥ 10 gm/dl.
  • Viable fetus.
  • No history of medical comorbidities.

Who cannot join

  • History of urogenital tract infection within 2 weeks before cesarean delivery.
  • Presence of clinical signs of infection at the time of delivery including PPROM and intraamniotic infection.
  • Medical comorbidities (hypertension, diabetes, etc.).
  • Hypersensitivity to any of the suture materials.
  • Women with abnormal placentation (placental abruption or placenta previa).
  • History of systemic corticosteroid intake during their pregnancy for 2 weeks or more.
Show all 9Show fewer
  • History of previous surgical site infection.
  • Immune-compromised women.
  • Women refused to participate in the study or could not obtain consent.

Trial locations and contacts

1 site in 1 country.

Ahmed N Afifi, MD contact

01098670624

dr_nagy.ahmed@yahoo.com

Egypt1 site
  • faculty of medicine, Kasr el ainy hospital, Cairo university

    Cairo, 11562

Other trials in Egypt

About this study

Official title: Comparative Analysis Between Different Suture Materials in Subcuticular Cesarean Wound Closure in Woman With BMI 40 or Greater in Cesarean Delivery: An Interventional Randomized Comparative Clinical Trial

1.1. Background and Rationale Cesarean section is one of the most common surgical procedures performed worldwide. The choice of suture material for closing the skin incision is crucial, as it can influence wound healing, the risk of wound complications, and the cosmetic outcome. Subcuticular suturing, a technique where the suture is placed just under the skin, is favored for its aesthetic benefits and reduced risk of infection. However, the type of suture material used can significantly impact these outcomes. This study aims to provide a comparative analysis of various subcuticular suture materials used in cesarean sections, focusing on wound complications and incision outcomes.

1.2. Objective of the Study The objective of this study is to compare the incidence of wound complications and the quality of incision outcomes associated with different subcuticular suture materials used in cesarean sections. By doing so, the investigators aim to identify the most effective suture material for minimizing wound complications and optimizing cosmetic results.

Read the detailed description

2.1. Surgical Techniques in Cesarean Section Cesarean section involves multiple surgical steps, including skin incision, uterine incision, and closure of the incisions. The subcuticular suturing technique is often preferred for skin closure due to its potential for better cosmetic results and lower infection rates compared to other methods like staples or interrupted sutures.

2.2. Types of Suture Materials

Suture materials can be broadly categorized into absorbable and non-absorbable, and further into monofilament and multifilament types. Common suture materials used in subcuticular skin closure include:

Absorbable Sutures: Poliglecaprone (Monocryl), Polyglactin (Vicryl), Polydioxanone (PDS).

Non-Absorbable Sutures: Nylon, Polypropylene (Prolene), Silk. 2.3. Previous Studies on Suture Materials in Cesarean Section Previous studies have explored the impact of different suture materials on wound healing, infection rates, and cosmetic outcomes. Research indicates varying results, with some studies favoring absorbable sutures for their reduced need for removal and lower infection rates, while others suggest non-absorbable sutures may provide stronger wound support. However, comprehensive comparative analyses specific to cesarean sections remain limited.

  1. Methodology 3.1. Study Design This study will use a prospective, randomized controlled trial design. Participants undergoing elective cesarean sections will be randomly assigned to receive subcuticular suturing with one of several suture materials.
Being tested
polyglactin 910, poliglecaprone 25, polypropylene, polyester
Keywords
cesarean section, wound complication, obesity, monocryl, vicryl, prolene, polyester
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • polyglactin 910Procedure or surgery

    Also called VICRYL

    75 PARTICIPANT, Vicryl suture was used in subcuticular suture

  • poliglecaprone 25Procedure or surgery

    Also called monocryl

    75 PARTICIPANT, monocryl suture was used in subcuticular suture

  • polypropyleneProcedure or surgery

    Also called prolene

    75 PARTICIPANT, Prolene suture was used in subcuticular suture

  • polyesterProcedure or surgery

    Also called ETHIBOND EXCEL Suture

    75 PARTICIPANT, Polyester suture was used in subcuticular suture

Study groups in NCT06543329
Study groupRoleWhat they receive
polyglactin 910Active comparator- Group A: (75) women with subcuticular suture polyglactin 910, braided, (VICRYL RAPIDE®; Ethicon) was used in subcuticular skin closure.
Receives: Procedure: polyglactin 910
poliglecaprone 25Active comparatorGroup A: (75) women with subcuticular suture poliglecaprone 25, (MONOCRYL) was used in subcuticular skin closure.
Receives: Procedure: poliglecaprone 25
polypropyleneActive comparatorGroup A: (75) women with subcuticular suture polypropylene, (PROLENE) was used in subcuticular skin closure.
Receives: Procedure: polypropylene
POLYESTERActive comparatorGroup A: (75) women with subcuticular suture POLYESTER, (ETHIBOND EXCEL Suture) was used in subcuticular skin closure.
Receives: Procedure: polyester

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the rate of any documented wound complication during the first six weeks postpartum

    This measure tracks the incidence of wound complications within six weeks postpartum, including infection, dehiscence, seroma, hematoma, ecchymosis, pus, delayed healing, and secondary suture needs.

    Measurement Tools:

    Clinical examinations during follow-up visits Patient self-reports Review of medical records

    Assessment Procedure:

    Patients will undergo follow-up visits at 2, 4, and 6 weeks postpartum. Complications will be documented through clinical exams, patient reports, and medical record reviews.

    Calculation:

    The rate is calculated as the number of patients with any wound complication divided by the total number of patients, expressed as a percentage.

    Measured: 6 weeks

Secondary outcomes (1)
  1. cosmetics satisfaction

    This measure assesses the cosmetic appearance of surgical wounds post-abdominal myomectomy.

    Measurement Tool:

    A standardized cosmetic appearance scale will be used, such as the Patient and Observer Scar Assessment Scale (POSAS).

    Assessment Procedure:

    Evaluations will be conducted at follow-up visits (2, 4, and 6 weeks postpartum) by both the patient and a clinician.

    Parameters Assessed:

    Scar color, texture, and overall appearance Patient satisfaction with the cosmetic outcome

    Calculation:

    Scores from the POSAS will be averaged to determine the overall cosmetic appearance rating.

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2024
  2. Study start1 Aug 2024 (estimated)
  3. Primary completion31 Jul 2025 (estimated)
  4. Study completion30 Aug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
This prospective interventional randomized comparative clinical trial was carried out on 300 pregnant women scheduled for elective caesarean section at operative theater
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06543329
Sponsor's protocol ID
AA-2024-3
Status last verified
Aug 2024
First submitted
27 Jul 2024
Last updated
9 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Rodel RL, Gray KM, Quiner TE, Bodea Braescu A, Gerkin R, Perlow JH. Cesarean wound closure in body mass index 40 or greater comparing suture to staples: a randomized clinical trial. Am J Obstet Gynecol MFM. 2021 Jan;3(1):100271. doi: 10.1016/j.ajogmf.2020.100271. Epub 2020 Oct 27.

    PubMed 33451603
  • Basha SL, Rochon ML, Quinones JN, Coassolo KM, Rust OA, Smulian JC. Randomized controlled trial of wound complication rates of subcuticular suture vs staples for skin closure at cesarean delivery. Am J Obstet Gynecol. 2010 Sep;203(3):285.e1-8. doi: 10.1016/j.ajog.2010.07.011.

    PubMed 20816153
  • Frishman GN, Schwartz T, Hogan JW. Closure of Pfannenstiel skin incisions. Staples vs. subcuticular suture. J Reprod Med. 1997 Oct;42(10):627-30.

    PubMed 9350017
  • Clay FS, Walsh CA, Walsh SR. Staples vs subcuticular sutures for skin closure at cesarean delivery: a metaanalysis of randomized controlled trials. Am J Obstet Gynecol. 2011 May;204(5):378-83. doi: 10.1016/j.ajog.2010.11.018. Epub 2010 Dec 31.

    PubMed 21195384
  • Tuuli MG, Rampersad RM, Carbone JF, Stamilio D, Macones GA, Odibo AO. Staples compared with subcuticular suture for skin closure after cesarean delivery: a systematic review and meta-analysis. Obstet Gynecol. 2011 Mar;117(3):682-690. doi: 10.1097/AOG.0b013e31820ad61e.

    PubMed 21343772
  • Nayak G B, Saha PK, Bagga R, Joshi B, Rohilla M, Gainder S, Sikka P. Wound complication among different skin closure techniques in the emergency cesarean section: a randomized control trial. Obstet Gynecol Sci. 2020 Jan;63(1):27-34. doi: 10.5468/ogs.2020.63.1.27. Epub 2019 Dec 23.

    PubMed 31970125
  • Aabakke AJM, Krebs L, Pipper CB, Secher NJ. Subcuticular suture compared with staples for skin closure after cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2013 Oct;122(4):878-884. doi: 10.1097/AOG.0b013e3182a5f0c3.

    PubMed 24084548
  • Buresch AM, Van Arsdale A, Ferzli M, Sahasrabudhe N, Sun M, Bernstein J, Bernstein PS, Ngai IM, Garry DJ. Comparison of Subcuticular Suture Type for Skin Closure After Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol. 2017 Sep;130(3):521-526. doi: 10.1097/AOG.0000000000002200.

    PubMed 28796687
  • Figueroa D, Jauk VC, Szychowski JM, Garner R, Biggio JR, Andrews WW, Hauth J, Tita AT. Surgical staples compared with subcuticular suture for skin closure after cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2013 Jan;121(1):33-8. doi: 10.1097/aog.0b013e31827a072c.

    PubMed 23262925

Questions about this trial

What is this clinical trial studying?

A study testing polyglactin 910, poliglecaprone 25 and polypropylene in people with Cesarean Wound Disruption With Postnatal Complication, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahmed N Afifi, MD (01098670624, dr_nagy.ahmed@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the rate of any documented wound complication during the first six weeks postpartum (time frame: 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06543329, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in